KPWS
GSK icon

Kestra Private Wealth Services’s GSK GSK Stock Holding History

Kestra Private Wealth Services’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$571K Sell
10,897
-383
-3% -$20.3K 0.01% 1162
2026
Q1 		$623K Sell
11,280
-2,847
-20% -$154K 0.01% 1090
2025
Q4 		$693K Sell
14,127
-1,146
-8% -$53.5K 0.01% 992
2025
Q3 		$659K Sell
15,273
-2,740
-15% -$107K 0.01% 966
2025
Q2 		$692K Sell
18,013
-1,085
-6% -$41.5K 0.01% 895
2025
Q1 		$740K Buy
19,098
+5,968
+45% +$218K 0.01% 794
2024
Q4 		$444K Sell
13,130
-4,071
-24% -$147K 0.01% 975
2024
Q3 		$703K Sell
17,201
-26,919
-61% -$1.1M 0.01% 748
2024
Q2 		$1.7M Buy
44,120
+17,140
+64% +$721K 0.03% 433
2024
Q1 		$1.16M Buy
26,980
+8,932
+49% +$368K 0.03% 518
2023
Q4 		$669K Sell
18,048
-7,706
-30% -$277K 0.02% 631
2023
Q3 		$934K Buy
25,754
+4,101
+19% +$146K 0.03% 486
2023
Q2 		$772K Buy
21,653
+2,433
+13% +$87.3K 0.03% 503
2023
Q1 		$684K Buy
19,220
+8,081
+73% +$283K 0.03% 508
2022
Q4 		$391K Buy
11,139
+694
+7% +$23.1K 0.02% 588
2022
Q3 		$307K Buy
10,445
+192
+2% +$7.28K 0.02% 643
2022
Q2 		$558K Sell
10,253
-6,163
-38% -$340K 0.03% 469
2022
Q1 		$894K Buy
16,416
+5,166
+46% +$281K 0.04% 404
2021
Q4 		$620K Buy
11,250
+2,900
+35% +$151K 0.03% 521
2021
Q3 		$399K Buy
8,350
+793
+10% +$39.8K 0.02% 604
2021
Q2 		$376K Sell
7,557
-2,469
-25% -$119K 0.02% 591
2021
Q1 		$447K Buy
10,026
+1,140
+13% +$51.7K 0.03% 480
2020
Q4 		$411K Buy
8,886
+2,172
+32% +$99.8K 0.03% 477
2020
Q3 		$316K Buy
+6,714
New +$336K 0.03% 474

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Kestra Private Wealth Services's GSK Position: Q2 2026 in Review

Kestra Private Wealth Services reduced its GSK (GSK) stake by 3.4% in Q2 2026, selling an estimated $20.3K and leaving 10,897 shares worth $571K. The position accounts for 0.01% of the portfolio, ranked #1162.

Kestra Private Wealth Services first reported a position in GSK in Q3 2020 and has held it in 24 quarters since. The position peaked at $1.7M in Q2 2024. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Kestra Private Wealth Services held 10,897 shares of GSK worth $571K as of Q2 2026.
  • Kestra Private Wealth Services sold 383 GSK shares in Q2 2026, an estimated $20.3K.
  • GSK made up 0.01% of Kestra Private Wealth Services's portfolio in Q2 2026, its #1162 holding.
  • Kestra Private Wealth Services first reported a position in GSK in Q3 2020 and has held it in 24 quarters since.
  • Kestra Private Wealth Services's GSK position peaked at $1.7M in Q2 2024.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Kestra Private Wealth Services's 13F filing for Q2 2026, filed 28 Jul 2026.